Status:
NOT_YET_RECRUITING
The Study on the Effectiveness of [68Ga]Ga-HBED-CC-DiAsp PET/CT in Calculating GFR and Predicting Residual Renal Function After Partial Nephrectomy
Lead Sponsor:
Luo Yaping
Collaborating Sponsors:
Peking Union Medical College Hospital
Conditions:
Kidney Neoplasms / Surgery
Glomerular Filtration Rate
Eligibility:
All Genders
18-88 years
Phase:
NA
Brief Summary
In subjects with different levels of renal function and no history of renal tumors, GFR is measured using \[68Ga\]Ga-HBED-CC-DiAsp PET/CT, the Gates method, and the 99mTc-DTPA dual plasma method. The ...
Detailed Description
\[68Ga\]Ga-HBED-CC-DiAsp PET/CT Imaging: After intravenous injection of \[68Ga\]Ga-HBED-CC-DiAsp, a Scout scan, low-dose CT scan, and a 30-minute dynamic PET scan are performed sequentially. The funct...
Eligibility Criteria
Inclusion
- Age \> 18 years;
- Written informed consent obtained.
Exclusion
- Patients with claustrophobia or fear of radiation;
- Women who are planning to conceive, pregnant, or breastfeeding;
- Patients unable to lie flat for 30 minutes;
- Patients or family members who cannot understand the conditions and objectives of the study, or who refuse to participate.
Key Trial Info
Start Date :
July 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 10 2025
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06973798
Start Date
July 1 2025
End Date
November 10 2025
Last Update
May 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking Union Medical College Hospital
Beijing, Beijing Municipality, China, 100730